Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 675,000 | 677,000 | 670,000 | 672,000 | 654,000 |
| Cost of Goods | 207,000 | 215,000 | 214,000 | 268,000 | 222,000 |
| Gross Profit | 468,000 | 462,000 | 456,000 | 404,000 | 432,000 |
| Operating Expenses | 343,000 | 354,000 | 354,000 | 554,000 | 392,000 |
| Operating Income | 125,000 | 108,000 | 102,000 | -150,000 | 40,000 |
| Interest Expense | 12,000 | 13,000 | 16,000 | 16,000 | 14,000 |
| Other Income | 4,000 | 1,000 | 1,000 | 0 | 1,000 |
| Pre-tax Income | 117,000 | 96,000 | 87,000 | -166,000 | 27,000 |
| Income Tax | 35,000 | 31,000 | 29,000 | 6,000 | 32,000 |
| Net Income Continuous | 82,000 | 65,000 | 58,000 | -172,000 | -5,000 |
| Net Income | $82,000 | $65,000 | $58,000 | $-172,000 | $-5,000 |
| EPS Basic Total Ops | 0.10 | 0.08 | 0.07 | -0.22 | -0.01 |
| EPS Basic Continuous Ops | 0.10 | 0.08 | 0.07 | -0.21 | -0.01 |
| EPS Diluted Total Ops | 0.10 | 0.08 | 0.07 | -0.22 | -0.01 |
| EPS Diluted Continuous Ops | 0.10 | 0.08 | 0.07 | -0.21 | -0.01 |
| EBITDA(a) | $125,000 | $108,000 | $102,000 | $-150,000 | $40,000 |